{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:09:35Z","timestamp":1778940575641,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omton.2025.201048","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:59:10Z","timestamp":1756828750000},"page":"201048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complex genetic landscape in CLL: Clinical impact on patients\u2019 survival and insights into the altered molecular pathways"],"prefix":"10.1016","volume":"33","author":[{"given":"Carlo","family":"Caputo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Donadelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariateresa","family":"Scupoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"D\u2019Arena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pietrantuono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Giliberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvestro","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Sperlongano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Cautela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardina","family":"Scafuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Facchiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia Maria","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Bocchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Misso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-6091","authenticated-orcid":false,"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201048_bib1","series-title":"Malattie del sangue e degli organi ematopoietici VI Edizione","author":"Castoldi","year":"2013"},{"key":"10.1016\/j.omton.2025.201048_bib2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib3","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute\u2013Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib4","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"Diagnostic criteria for monoclonal B-cell lymphocytosis","volume":"130","author":"Marti","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.201048_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1468-0734.2000.00002.x","article-title":"Morphological and Immunophenotypic Features of Chronic Lymphocytic Leukemia","volume":"4","author":"Matutes","year":"2000","journal-title":"Rev. Clin. Exp. Hematol."},{"key":"10.1016\/j.omton.2025.201048_bib8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bjh.14132","article-title":"The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic\/molecular markers in the LRF CLL4 trial","volume":"174","author":"Oscier","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.201048_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM199009133231105","article-title":"Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities","volume":"323","author":"Juliusson","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.201048_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cancergen.2013.01.003","article-title":"Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease","volume":"206","author":"Rodr\u00edguez-Vicente","year":"2013","journal-title":"Cancer Genet."},{"key":"10.1016\/j.omton.2025.201048_bib11","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.201048_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.13862","article-title":"A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia","volume":"94","author":"Hernandez","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2025.201048_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.blre.2008.05.003","article-title":"Prognostic markers in chronic lymphocytic leukemia: A comprehensive review","volume":"23","author":"Van Bockstaele","year":"2009","journal-title":"Blood Rev."},{"key":"10.1016\/j.omton.2025.201048_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.critrevonc.2016.06.003","article-title":"Chronic lymphocytic leukaemia","volume":"104","author":"Scarf\u00f2","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.omton.2025.201048_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3324\/haematol.2012.069369","article-title":"Clinical implications of the molecular genetics of chronic lymphocytic leukemia","volume":"98","author":"Foa","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2025.201048_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/asheducation-2010.1.90","article-title":"Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion","volume":"2010","author":"Ding","year":"2010","journal-title":"Hematology"},{"key":"10.1016\/j.omton.2025.201048_bib17","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V89.7.2516","article-title":"11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis","volume":"89","author":"D\u00f6hner","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib18","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/annonc\/mdq236","article-title":"Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories","volume":"21","author":"Fiegl","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omton.2025.201048_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2141.2003.04265.x","article-title":"Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia","volume":"121","author":"Dewald","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.201048_bib20","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1182\/blood-2007-07-099432","article-title":"Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia","volume":"112","author":"Kujawski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib21","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2010-12-327858","article-title":"Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia","volume":"118","author":"Ouillette","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-08-1630","article-title":"The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201048_bib23","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","article-title":"TP53 Mutation and Survival in Chronic Lymphocytic Leukemia","volume":"28","author":"Zenz","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.omton.2025.201048_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1182\/asheducation-2011.1.104","article-title":"Using the biology of chronic lymphocytic leukemia to choose treatment","volume":"2011","author":"Hillmen","year":"2011","journal-title":"Hematology. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.omton.2025.201048_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/asheducation-2009.1.440","article-title":"State-of-the-art treatment of chronic lymphocytic leukemia","volume":"2009","author":"Hallek","year":"2009","journal-title":"Hematology"},{"key":"10.1016\/j.omton.2025.201048_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omton.2025.201048_bib27","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.omton.2025.201048_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2040620711404469","article-title":"Treatment options for high-risk chronic lymphocytic leukaemia","volume":"2","author":"Hewamana","year":"2011","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.omton.2025.201048_bib29","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/s41598-025-86876-1","article-title":"Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model","volume":"15","author":"Pfeuffer","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.201048_bib30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3324\/haematol.2021.278304","article-title":"The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation","volume":"107","author":"Visentin","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2025.201048_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cyto.b.21595","article-title":"Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project","volume":"94","author":"Rawstron","year":"2018","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.omton.2025.201048_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3960\/jslrt.19041","article-title":"Differential diagnosis of chronic lymphocytic leukemia\/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma","volume":"60","author":"Yoshino","year":"2020","journal-title":"J. Clin. Exp. Hematop."},{"key":"10.1016\/j.omton.2025.201048_bib34","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1182\/blood-2016-08-737650","article-title":"Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219-234","volume":"128","author":"Rai","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2025.201048_bib36","first-page":"1","article-title":"Current Perspectives on Therapy for Chronic Lymphocytic Leukemia","volume":"40","author":"Awan","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.omton.2025.201048_bib37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2005-05-2093","article-title":"Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia","volume":"107","author":"Mayr","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201048_bib38","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function\u2013structure and function\u2013mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omton.2025.201048_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2141.2003.04265.x","article-title":"Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia","volume":"121","author":"Dewald","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.201048_bib39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.8023159","article-title":"High-Resolution Structure of the Oligomerization Domain of p53 by Multidimensional NMR","volume":"265","author":"Clore","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.201048_bib40","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/80734","article-title":"The Protein Data Bank and the challenge of structural genomics","volume":"7","author":"Berman","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.omton.2025.201048_bib41","doi-asserted-by":"crossref","first-page":"W314","DOI":"10.1093\/nar\/gku411","article-title":"DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach","volume":"42","author":"Pires","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2025.201048_bib42","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/bioinformatics\/btw192","article-title":"INPS-MD: a web server to predict stability of protein variants from sequence and structure","volume":"32","author":"Savojardo","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omton.2025.201048_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nmeth.2289","article-title":"Interactome3D: adding structural details to protein networks","volume":"10","author":"Mosca","year":"2013","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:38:05Z","timestamp":1778938685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2950329925001171"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201048","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complex genetic landscape in CLL: Clinical impact on patients\u2019 survival and insights into the altered molecular pathways","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201048"}}